Below are the most recent publications written about "Osteoarthritis, Knee" by people in Profiles.
-
Xu S, Driban JB, Prakash PS, McAlindon TE, Eaton CB, Lu B. Metabolomic Signatures of Dietary Patterns and Incident Radiographic Knee Osteoarthritis: A Case-Cohort Study From the Osteoarthritis Initiative. J Rheumatol. 2026 Apr 01; 53(4):443-449.
-
Zheng H, Ash AS, Liu SH, Yousef M, Allison J, Ayers DC. Satisfied but Failed: Patient Satisfaction Compared with Total Knee Arthroplasty Success Defined by the U.S. Centers for Medicare & Medicaid Services. J Bone Joint Surg Am. 2026 May 20; 108(10):721-728.
-
Lo GH, Tran ST, Patarini JC, Lee JC, McAlindon TE, Kriska AM, Rockette-Wagner B, Eaton CB, Hochberg MC, Kwoh CK, Nevitt MC, Driban JB. Gardening/yardwork over a lifetime is associated with less symptomatic knee osteoarthritis: data from the Osteoarthritis Initiative. Clin Rheumatol. 2026 Feb; 45(2):1523-1532.
-
Uhlrich SD, Mazzoli V, Silder A, Finlay AK, Kogan F, Gold GE, Delp SL, Beaupre GS, Kolesar JA. Personalised gait retraining for medial compartment knee osteoarthritis: a randomised controlled trial. Lancet Rheumatol. 2025 Oct; 7(10):e708-e718.
-
Angeles JPM, Abella MKIL, McGovern AG, Espiritu JRB, Bankston ME, Arora P, Koltsov JCB, Finlay AK, Giori NJ, Huddleston JI, Maloney WJ, Goodman SB, Amanatullah DF. Patients Who Have Limited English Proficiency Are More Likely to Receive Elective Total Joint Arthroplasty. J Arthroplasty. 2026 03; 41(3):674-679.
-
Tambiah J, Kennedy S, Swearingen C, McAlindon T, Yazici Y. Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. Rheumatology (Oxford). 2025 05 01; 64(5):2583-2590.
-
Ayers DC, Zheng H, Yang W, Yousef M. The Chitranjan S. Ranawat Award: Factors That Predict Outcome Five Years Following Total Knee Arthroplasty. J Arthroplasty. 2025 Jul; 40(7S1):S12-S19.
-
Murrietta AJ, Bonano JC, Finlay AK, Huddleston JI, Goodman SB, Maloney WJ, Amanatullah DF. Recommending Surgery Increases Patient Satisfaction With Their Arthroplasty Surgeon. J Arthroplasty. 2025 08; 40(8):1967-1971.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Lopez VA, Kennedy S, Fineman MS, Simsek I, Solomon E, Mcalindon TE. A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Clin Exp Rheumatol. 2025 May; 43(5):847-853.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Britt J, Kennedy S, Fineman MS, Simsek I, Solomon E, McAlindon TE. A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis. Clin Exp Rheumatol. 2025 May; 43(5):854-860.